Literature DB >> 24043899

RON receptor tyrosine kinase, a negative regulator of inflammation, is decreased during simian immunodeficiency virus-associated central nervous system disease.

Daniele C Cary1, Janice E Clements, Andrew J Henderson.   

Abstract

Expressed on tissue-resident macrophages, the receptor tyrosine kinase, recepteur d'orgine nantais (RON), functions to maintain inflammation homeostasis by activating genes that promote wound repair and resolve inflammation while repressing genes that perpetuate tissue damage and cell death. Chronic HIV-1 infection is associated with dysregulated inflammation, and we hypothesize that diminished RON expression contributes to the development of end organ diseases such as HIV-1-associated CNS disease. To explore RON function in vivo, we used CNS tissue from a well-characterized SIV macaque model and examined the temporal regulation of RON in the brain during the course of infection. Following prolonged SIV infection, RON expression was inversely correlated with the development of CNS disease; RON was maintained in animals that did not develop CNS lesions and was reduced in SIV-infected macaques that demonstrated moderate to severe inflammatory lesions. Arginase-1 expression was reduced in the brain during late infection, whereas expression of the inflammatory genes, IL-12p40 and TNF-α, was elevated. To validate a role for RON in regulating HIV-1 in primary cells, we used human tissue-resident macrophages isolated from tonsil as a tractable cell model. RON signaling in tissue-resident macrophages, both ligand dependent and independent, limited HIV-1 replication. Furthermore, prolonged HIV-1 infection in vitro resulted in downregulation of RON. We propose a model in which, following chronic HIV-1 infection in the brain, RON expression is decreased, genes that quell inflammation are repressed, and inflammatory mediators are induced to promote tissue inflammation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24043899      PMCID: PMC3819118          DOI: 10.4049/jimmunol.1300797

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  64 in total

1.  Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors.

Authors:  J S Gerber; D M Mosser
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

2.  The role of the receptor tyrosine kinase Ron in nickel-induced acute lung injury.

Authors:  Susan A McDowell; Ali Mallakin; Cindy J Bachurski; Kenya Toney-Earley; Daniel R Prows; Theresa Bruno; Klaus H Kaestner; David P Witte; Hector Melin-Aldana; Sandra J F Degen; George D Leikauf; Susan E Waltz
Journal:  Am J Respir Cell Mol Biol       Date:  2002-01       Impact factor: 6.914

3.  Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects.

Authors:  Xu-Ming Dai; Gregory R Ryan; Andrew J Hapel; Melissa G Dominguez; Robert G Russell; Sara Kapp; Vonetta Sylvestre; E Richard Stanley
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

4.  STK receptor tyrosine kinase regulates susceptibility to infection with Listeria monocytogenes.

Authors:  Michael A Lutz; Francine Gervais; Alan Bernstein; Arthur L Hattel; Pamela H Correll
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

5.  High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis.

Authors:  M C Zink; K Suryanarayana; J L Mankowski; A Shen; M Piatak; J P Spelman; D L Carter; R J Adams; J D Lifson; J E Clements
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

6.  Arginase I expression and activity in human mononuclear cells after injury.

Authors:  J B Ochoa; A C Bernard; W E O'Brien; M M Griffen; M E Maley; A K Rockich; B J Tsuei; B R Boulanger; P A Kearney; S M Morris
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

7.  Regulation of the RON receptor tyrosine kinase expression in macrophages: blocking the RON gene transcription by endotoxin-induced nitric oxide.

Authors:  M H Wang; H L Fung; Y Q Chen
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

8.  Surgery induces human mononuclear cell arginase I expression.

Authors:  B J Tsuei; A C Bernard; M D Shane; L A Shirley; M E Maley; B R Boulanger; P A Kearney; J B Ochoa
Journal:  J Trauma       Date:  2001-09

9.  Activation of the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase by macrophage-stimulating protein results in the induction of arginase activity in murine peritoneal macrophages.

Authors:  Amy C Morrison; Pamela H Correll
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

10.  FcgammaRIIa genotype predicts progression of HIV infection.

Authors:  Donald N Forthal; Gary Landucci; Jay Bream; Lisa P Jacobson; Tran B Phan; Benjamin Montoya
Journal:  J Immunol       Date:  2007-12-01       Impact factor: 5.422

View more
  7 in total

1.  Neuroprotective effects of the anti-cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disorders.

Authors:  Wolf Wrasidlo; Leslie A Crews; Igor F Tsigelny; Emily Stocking; Valentina L Kouznetsova; Diana Price; Amy Paulino; Tania Gonzales; Cassia R Overk; Christina Patrick; Edward Rockenstein; Eliezer Masliah
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

Review 2.  The MST1R/RON Tyrosine Kinase in Cancer: Oncogenic Functions and Therapeutic Strategies.

Authors:  Alex Cazes; Betzaira G Childers; Edgar Esparza; Andrew M Lowy
Journal:  Cancers (Basel)       Date:  2022-04-18       Impact factor: 6.575

Review 3.  Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders.

Authors:  Jerel Adam Fields; Wilmar Dumaop; Leslie Crews; Anthony Adame; Brian Spencer; Jeff Metcalf; Johnny He; Edward Rockenstein; Eliezer Masliah
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

4.  Whole-exome sequencing identifies MST1R as a genetic susceptibility gene in nasopharyngeal carcinoma.

Authors:  Wei Dai; Hong Zheng; Arthur Kwok Leung Cheung; Clara Sze-man Tang; Josephine Mun Yee Ko; Bonnie Wing Yan Wong; Merrin Man Long Leong; Pak Chung Sham; Florence Cheung; Dora Lai-Wan Kwong; Roger Kai Cheong Ngan; Wai Tong Ng; Chun Chung Yau; Jianji Pan; Xun Peng; Stewart Tung; Zengfeng Zhang; Mingfang Ji; Alan Kwok-Shing Chiang; Anne Wing-Mui Lee; Victor Ho-Fun Lee; Ka-On Lam; Kwok Hung Au; Hoi Ching Cheng; Harry Ho-Yin Yiu; Maria Li Lung
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-07       Impact factor: 11.205

5.  Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics.

Authors:  Ren-Bo Ding; Ping Chen; Barani Kumar Rajendran; Xueying Lyu; Haitao Wang; Jiaolin Bao; Jianming Zeng; Wenhui Hao; Heng Sun; Ada Hang-Heng Wong; Monica Vishnu Valecha; Eun Ju Yang; Sek Man Su; Tak Kan Choi; Shuiming Liu; Kin Iong Chan; Ling-Lin Yang; Jingbo Wu; Kai Miao; Qiang Chen; Joong Sup Shim; Xiaoling Xu; Chu-Xia Deng
Journal:  Nat Commun       Date:  2021-05-24       Impact factor: 14.919

6.  Porphyromonas gingivalis-mediated signaling through TLR4 mediates persistent HIV infection of primary macrophages.

Authors:  Luis M Agosto; Juliane B Hirnet; Daniel H Michaels; Yazdani B Shaik-Dasthagirisaheb; Frank C Gibson; Gregory Viglianti; Andrew J Henderson
Journal:  Virology       Date:  2016-09-16       Impact factor: 3.616

7.  Effects of HIV gp120 on Neuroinflammation in Immunodeficient vs. Immunocompetent States.

Authors:  Taxiarhia J Arabatzis; Alexa A Wakley; Virginia D McLane; Dalton Canonico; Ling Cao
Journal:  J Neuroimmune Pharmacol       Date:  2020-07-06       Impact factor: 7.285

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.